Literature DB >> 2905066

Family screening in medullary thyroid carcinoma presenting without a family history.

B A Ponder1, N Finer, R Coffey, C L Harmer, M Maisey, M G Ormerod, M E Pembrey, M A Ponder, P Rosswick, S Shalet.   

Abstract

Systematic screening of the families of a series of 39 patients with apparently sporadic medullary thyroid carcinoma detected seven new cases in four families. A negative family history in a patient presenting with medullary thyroid carcinoma is not reliable in excluding familial disease, and family screening should be considered for new patients with medullary thyroid carcinoma.

Entities:  

Mesh:

Year:  1988        PMID: 2905066

Source DB:  PubMed          Journal:  Q J Med        ISSN: 0033-5622


  10 in total

Review 1.  Multiple endocrine neoplasia type 2 and the practice of molecular medicine.

Authors:  C Eng
Journal:  Rev Endocr Metab Disord       Date:  2000-11       Impact factor: 6.514

2.  Ret-proto-oncogene analysis in medullary thyroid carcinoma.

Authors:  D A O'Keeffe; A D Hill; K Sheahan; F Ryan; D Barton; R J Fitzgerald; E W McDermott; N J O'Higgins
Journal:  Ir J Med Sci       Date:  1998 Oct-Dec       Impact factor: 1.568

3.  Hereditary medullary thyroid cancer in Slovenia--genotype-phenotype correlations.

Authors:  Damijan Bergant; Marko Hocevar; Nikola Besic; Damjan Glavac; Branka Korosec; Simon Caserman
Journal:  Wien Klin Wochenschr       Date:  2006-07       Impact factor: 1.704

Review 4.  Thyroid cancer: a review of treatment and follow-up.

Authors:  L Vini; C Harmer; V R McCready
Journal:  Ann Nucl Med       Date:  1996-02       Impact factor: 2.668

5.  Prognostic factors in medullary thyroid carcinoma: evaluation of 741 patients from the German Medullary Thyroid Carcinoma Register.

Authors:  F Raue; J Kotzerke; D Reinwein; S Schröder; H D Röher; H Deckart; R Höfer; M Ritter; F Seif; H Buhr
Journal:  Clin Investig       Date:  1993-01

6.  [Progress in the diagnosis and therapy of C cell carcinoma of the thyroid gland].

Authors:  A Frilling; P E Goretzki; H D Röher
Journal:  Langenbecks Arch Chir       Date:  1990

7.  Analysis of RET proto-oncogene abnormalities in patients with MEN 2A, MEN 2B, familial or sporadic medullary thyroid carcinoma.

Authors:  E Chiefari; D Russo; D Giuffrida; G A Zampa; D Meringolo; F Arturi; I Chiodini; D Bianchi; M Attard; V Trischitta; R Bruno; P Giannasio; A Pontecorvi; S Filetti
Journal:  J Endocrinol Invest       Date:  1998-06       Impact factor: 4.256

8.  Presymptomatic screening for medullary thyroid carcinoma in patients with multiple endocrine neoplasia type 2A.

Authors:  A Frilling; H D Röher; B A Ponder
Journal:  World J Surg       Date:  1994 Jul-Aug       Impact factor: 3.352

9.  Presymptomatic genetic screening in families with multiple endocrine neoplasia type 2.

Authors:  A Frilling; W Höppner; C Eng; L Mulligan; F Raue; C E Broelsch
Journal:  J Mol Med (Berl)       Date:  1995-05       Impact factor: 4.599

10.  Childhood thyroid cancer in England and Wales.

Authors:  H R Harach; E D Williams
Journal:  Br J Cancer       Date:  1995-09       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.